bio-elixia spotted in stores in singapore, page-31

From the 2011 annual report.

While personal care is an important strategic direction for Phosphagenics in its quest to financial independence, its primary focus remains on the delivery of drugs

I think it is important to remember that POH are not a cosmetics company and as the above statement suggests the primary focus is drug delivery.

Whilst I don't dispute the debate on marketing, POS, the need for ground staff, full tilt advertising, the company did make it very clear that it will not lose focus on the primary target - oxypatch.

POH simply do not have the resources and funds to do what we all want and that similar to the giant cosmetics companies.

Some may ask then why do it at all, if your not going to commit 100% of everything.
The answer in my opinion is 2 fold.
Firstly POH made it clear that it was an important part of strategy in earning revenue to make the company financially independent.
So, in other words it's a revenue generator.
The other aspect is that maybe the global aspect has all come a bit quicker than expected, so POH have to re-adjust the goal posts as they go, seen by the recent allocation of $5m to the Elixia development.

The other option was for POH to sit around developing other pipeline products which will take time to start providing revenue and then we would be asking why aren't POH doing anything to create revenue and avoid CR and dilution.

I prefer the option they are taking. Even if revenues come in at $6-$10m for the year, that's a start, and $6-10m more than we would have had otherwise.